The Efficacy of Potassium-Competitive Acid Blocker Compared With Double Dose of Proton Pump Inhibitor in Patients With Refractory Gastro-Esophageal Reflux Disease: A Case-Control Study
In patients with refractory GERD symptoms, PCAB therapy had effects corresponding to those of a double split dose of PPIs. PCAB therapy was therefore deemed superior to PPIs, especially in patients with abnormal AETs.
Authors
- Na Rae Lim (ORCID: https://orcid.org/0000-0002-8596-3054)
- Woo Chul Chung (ORCID: https://orcid.org/0000-0003-1044-0440)
Institutions
- The Catholic University of Korea St. Vincent's Hospital (KR)
Publication Details
- Journal
- The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Published
- 2025-12-05
- DOI
- https://doi.org/10.7704/kjhugr.2025.0045
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00